Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Y Liu

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Plos One|January 10, 2018
Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trialSanjiv M Baxi, Eric Vittinghoff, Peter Bacchetti, et al.
AIDS Care|September 2, 2024
Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative explorationJennifer Velloza, Albert Y Liu, Ariana W K Katz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2018
Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048Albert Y Liu, Jingyang Zhang, Peter L Anderson, et al.
JMIR Public Health and Surveillance|February 5, 2025
The Effects of MyChoices and LYNX Mobile Apps on HIV Testing and Pre-Exposure Prophylaxis Use by Young US Sexual Minority Men: Results From a National Randomized Controlled TrialKatie B Biello, Kenneth H Mayer, Hyman Scott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2017
Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling StudySamuel M Jenness, Kevin M Weiss, Steven M Goodreau, et al.
AIDS Patient Care and Stds|November 15, 2014
Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementationAlbert Y Liu, Nancy A Hessol, Eric Vittinghoff, et al.
Plos One|January 15, 2014
Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)Albert Y Liu, Qiyun Yang, Yong Huang, et al.
Journal of Women'S Health (2002)|October 19, 2021
Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 TrialSarah T Roberts, Imogen Hawley, Ellen Luecke, et al.
AIDS (London, England)|June 22, 2022
The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptionsParya Saberi, Marie C D Stoner, Kristin Ming, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2013
Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United StatesAlbert Y Liu, Eric Vittinghoff, Kata Chillag, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Plos One|January 10, 2018
Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trialSanjiv M Baxi, Eric Vittinghoff, Peter Bacchetti, et al.
AIDS Care|September 2, 2024
Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative explorationJennifer Velloza, Albert Y Liu, Ariana W K Katz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2018
Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048Albert Y Liu, Jingyang Zhang, Peter L Anderson, et al.
JMIR Public Health and Surveillance|February 5, 2025
The Effects of MyChoices and LYNX Mobile Apps on HIV Testing and Pre-Exposure Prophylaxis Use by Young US Sexual Minority Men: Results From a National Randomized Controlled TrialKatie B Biello, Kenneth H Mayer, Hyman Scott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2017
Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling StudySamuel M Jenness, Kevin M Weiss, Steven M Goodreau, et al.
AIDS Patient Care and Stds|November 15, 2014
Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementationAlbert Y Liu, Nancy A Hessol, Eric Vittinghoff, et al.
Plos One|January 15, 2014
Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)Albert Y Liu, Qiyun Yang, Yong Huang, et al.
Journal of Women'S Health (2002)|October 19, 2021
Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 TrialSarah T Roberts, Imogen Hawley, Ellen Luecke, et al.
AIDS (London, England)|June 22, 2022
The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptionsParya Saberi, Marie C D Stoner, Kristin Ming, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2013
Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United StatesAlbert Y Liu, Eric Vittinghoff, Kata Chillag, et al.
Pageof 10